Platelet survival in patients with rheumatic heart disease.
D000244:Adenosine Diphosphate; D001024:Aortic Valve Stenosis / Q000097:blood / Q000150:complications; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D002470:Cell Survival; D002860:Chromium Radioisotopes; D003094:Collagen; D006801:Humans; D008944:Mitral Valve Insufficiency / Q000097:blood / Q000150:complications; D008946:Mitral Valve Stenosis / Q000097:blood / Q000150:complications; D010973:Platelet Adhesiveness; D012214:Rheumatic Heart Disease / Q000097:blood* / Q000150:complications; D013442:Sulfinpyrazone / Q000494:pharmacology / Q000627:therapeutic use; D013923:Thromboembolism / Q000097:blood / Q000150:complications; D013997:Time Factors
D002860:Chromium Radioisotopes; D000244:Adenosine Diphosphate; D003094:Collagen; D013442:Sulfinpyrazone